Imagion Biosystems, Inc. clinical trial pipeline
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19
What changed in the last 30 days
1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates
New trial filings, last 30 days
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-10-21 | NCT07885683 MagSense® Human Epidermal Growth Factor Receptor 2 (HER2) Imaging Agent (MSH2IA) | Phase 1/2 | Recruiting |
Active trials by phase
| Phase 1/2 | 1 |
Disease areas by active trials
Breast Cancer (1) · HER2-Positive Cancer (1)
Get alerts when Imagion Biosystems, Inc.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.